Federal contract award

FA238423CB002

CHEMICAL, BIOLOGICAL, RADIOLOGICA, NUCLEAR (CBRN) TACTICAL EDGE TARGETING

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Defense
OfficeFA2384 USAF AFMC AFRL PZL AFRL RAKH
NAICS541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
PSCAJ12 — GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; APPLIED RESEARCH
Parent award / vehicleNot reported
Set-asideNO SET ASIDE USED.
Pricing typeCOST PLUS FIXED FEE
Obligations$17.7M
Current contract value$19.3M
Potential contract value / ceiling$19.3M
Start dateJul 20, 2023
Current end dateOct 19, 2028
Potential end dateOct 19, 2028
Latest award activityJun 1, 2026
Source loadedSep 19, 2026

Funding and modification history

Showing the latest 16 of 16 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Jun 1, 2026P00015$1.9MCHEMICAL, BIOLOGICAL, RADIOLOGICAL AND NUCLEAR (CBRN) TACTICAL EDGE TARGETING
Apr 8, 2026P00014$295.0KCHEMICAL, BIOLOGICAL, RADIOLOGICAL AND NUCLEAR (CBRN) TACTICAL EDGE TARGETING
Mar 25, 2026P00013$234.5KCHEMICAL, BIOLOGICAL, RADIOLOGICAL AND NUCLEAR (CBRN) TACTICAL EDGE TARGETING
Feb 11, 2026P00012$0CHEMICAL, BIOLOGICAL, RADIOLOGICAL AND NUCLEAR (CBRN) TACTICAL EDGE TARGETING
Jan 7, 2026P00011$0CHEMICAL, BIOLOGICAL, RADIOLOGICAL AND NUCLEAR (CBRN) TACTICAL EDGE TARGETING
Dec 17, 2025P00010$887.1KCHEMICAL, BIOLOGICAL, RADIOLOGICAL AND NUCLEAR (CBRN) TACTICAL EDGE TARGETING
Sep 10, 2025P00009$1.7MCHEMICAL, BIOLOGICAL, RADIOLOGICAL AND NUCLEAR (CBRN) TACTICAL EDGE TARGETING - INCREMENTAL FUNDING
Aug 11, 2025P00008$-5.3KCHEMICAL, BIOLOGICAL, RADIOLOGICAL AND NUCLEAR (CBRN) TACTICAL EDGE TARGETING
Jun 12, 2025P00007$-1.1MCHEMICAL, BIOLOGICAL, RADIOLOGICAL AND NUCLEAR (CBRN) TACTICAL EDGE TARGETING
Mar 14, 2025P00006$237.5KCHEMICAL, BIOLOGICAL, RADIOLOGICA, NUCLEAR (CBRN) TACTICAL EDGE TARGETING
Mar 7, 2025P00005$3.5MCHEMICAL, BIOLOGICAL, RADIOLOGICAL AND NUCLEAR (CBRN) TACTICAL EDGE TARGETING
Feb 21, 2025P00004$2.1MCHEMICAL, BIOLOGICAL, RADIOLOGICAL AND NUCLEAR (CBRN) TACTICAL EDGE TARGETING
Sep 11, 2024P00003$1.9MCHEMICAL, BIOLOGICAL, RADIOLOGICAL AND NUCLEAR (CBRN) TACTICAL EDGE TARGETING
Feb 6, 2024P00002$243.7KCHEMICAL, BIOLOGICAL, RADIOLOGICAL, NUCLEAR (CBRN) TACTICAL EDGE TARGETING - INCREMENTAL FUNDING
Sep 25, 2023P00001$150.0KCHEMICAL, BIOLOGICAL, RADIOLOGICAL, NUCLEAR (CBRN) TACTICAL EDGE TARGETING - INCREMENTAL FUNDING
Jul 20, 20230$750.0KCHEMICAL, BIOLOGICAL, RADIOLOGICA, NUCLEAR (CBRN) TACTICAL EDGE TARGETING

Estimated positioning window

Oct 19, 2027 – Apr 19, 2028

Recompete signal:
55/100

Why this recompete signal

Contract timing and recorded acquisition signals at the time of calculation.

Stored score: 55/100. Available recorded signals: 50 points.

Contract end 2028-10-19 (718 days from calculation)
+25 points
1 historical awards in this buyer and category group
+0 points
16 recorded award transactions
+10 points
Latest award action: 2026-06-01
+5 points
Parent award identifier recorded
+0 points
Solicitation identifier recorded
+10 points
Linked official forecast
+0 points
Calculated on
2026-11-01 10:17:53.997580+00:00

The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.

Rule-based research score; it does not measure your chance of winning.

This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.

USAspending award record

. Rule-based research score; positioning dates are estimates.

Recompete score calculated Nov 1, 2026.

Research next steps

  1. Check the linked forecast or SAM for a confirmed solicitation and current timing.
  2. Check the stated set-aside against the solicitation and current certifications.
  3. Review the award scope and buyer evidence before making a bid/no-bid decision.